Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.8298
+0.0196
+(2.42%)
At close: February 21 at 5:25:31 PM GMT+1
Loading Chart for 2HQ.HA
DELL
- Previous Close
0.8102 - Open
0.8188 - Bid 0.9016 x --
- Ask 0.9200 x --
- Day's Range
0.8188 - 0.8298 - 52 Week Range
0.8102 - 2.8010 - Volume
0 - Avg. Volume
5 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 7, 2025 - Apr 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2HQ.HA
View MorePerformance Overview: 2HQ.HA
Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
2HQ.HA
38.74%
S&P 500
2.24%
1-Year Return
2HQ.HA
50.10%
S&P 500
20.70%
3-Year Return
2HQ.HA
83.57%
S&P 500
38.27%
5-Year Return
2HQ.HA
81.46%
S&P 500
80.16%
Compare To: 2HQ.HA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.8298
+2.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3900
+1.30%
Mkt Cap CAD 22.026M
Industry Drug Manufacturers—Specialty & Generic
0.0000
0.00%
Mkt Cap 14,977
Industry Drug Manufacturers—Specialty & Generic
1.2900
+3.20%
Mkt Cap CAD 116.931M
Industry Drug Manufacturers—Specialty & Generic
2.7800
+1.83%
Mkt Cap CAD 1.063B
Industry Drug Manufacturers—Specialty & Generic
10.20
+2.00%
Mkt Cap CAD 2.412B
Industry Drug Manufacturers—Specialty & Generic
6.25
+0.64%
Mkt Cap CAD 1.182B
Industry Drug Manufacturers—Specialty & Generic
1.8200
-0.55%
Mkt Cap CAD 229.715M
Industry Drug Manufacturers—Specialty & Generic
1.4100
-1.40%
Mkt Cap 1.089B
Industry Drug Manufacturers—Specialty & Generic
1.3100
+1.55%
Mkt Cap 165.344M
Industry Drug Manufacturers—Specialty & Generic
5.89
+0.51%
Mkt Cap 323.267M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 2HQ.HA
View MoreValuation Measures
As of 2/21/2025
Market Cap
840.77M
Enterprise Value
956.53M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.85
Price/Book (mrq)
0.23
Enterprise Value/Revenue
1.21
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--